Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Signs MoUs with Shri Krishna Ayush University and Dabur India
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Subscribe To Our Newsletter & Stay Updated
